Related Experiment Video
Updated: May 30, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
[Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice]
Abstract:
The effects of anti-parkinsonian drug hemantane [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.) and/or antibiotic drug doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) (4 x 20 mg/kg, i. p.) were studied in elevated plus maze test on C57BL/6 mice. On second day after injection, MPTP decreased the locomot or activity in comparison to saline. Acute administration of hemantane or doxycycline failed to influence locomotion in mice, while their combination normalized motor activity. The results obtained confirm the role of inflammatory processes in parkinsonism and suggest expediency of combined pharmacotherapy of neurodegenerative diseases.
Insights
The anti-parkinsonian drug hemantane and antibiotic doxycycline combined normalized motor activity in mice treated with MPTP, suggesting inflammation plays a role in Parkinson's disease.
Area of Science:
- Neuropharmacology
- Neuroimmunology
- Toxicology
Context:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor deficits.
- Neuroinflammation is increasingly recognized as a key contributor to PD pathogenesis.
- The neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) is a common model for inducing PD-like symptoms in rodents.
Purpose:
- To investigate the effects of hemantane and doxycycline, alone and in combination, on MPTP-induced motor deficits in C57BL/6 mice.
- To explore the potential role of inflammatory processes in MPTP-induced parkinsonism.
- To evaluate the therapeutic potential of combined pharmacotherapy for neurodegenerative diseases.
Summary:
- MPTP administration significantly reduced locomotor activity in mice compared to saline controls.
- Single administration of hemantane or doxycycline did not affect locomotion.
- Combined administration of hemantane and doxycycline effectively normalized motor activity in MPTP-treated mice.
Impact:
- These findings support the involvement of inflammatory mechanisms in the development of parkinsonism.
- The study suggests that a combination therapy involving hemantane and doxycycline may be a promising approach for treating neurodegenerative diseases like Parkinson's.
- This research highlights the potential of targeting inflammation in the pharmacotherapy of neurodegenerative conditions.
